Cargando…

High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series

Background: The evidence on high-dose ifosfamide (HD-IFO) use in patients with relapsed osteosarcoma is limited. We performed a retrospective study to analyze HD-IFO activity. Methods: Patients with osteosarcoma relapsed after standard treatment [methotrexate, doxorubicin, cisplatin +/− ifosfamide (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palmerini, Emanuela, Setola, Elisabetta, Grignani, Giovanni, D’Ambrosio, Lorenzo, Comandone, Alessandro, Righi, Alberto, Longhi, Alessandra, Cesari, Marilena, Paioli, Anna, Hakim, Rossella, Pierini, Michela, Marchesi, Emanuela, Vanel, Daniel, Pignochino, Ymera, Donati, Davide Maria, Picci, Piero, Ferrari, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692098/ https://www.ncbi.nlm.nih.gov/pubmed/33142760 http://dx.doi.org/10.3390/cells9112389

Ejemplares similares

High-grade focal areas in low-grade central osteosarcoma: high-grade or still low-grade osteosarcoma?
por: Righi, Alberto, et al.
Publicado: (2015)

Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone
por: Palmerini, E., et al.
Publicado: (2016)

Osteosarcoma follow-up: chest X-ray or computed tomography?
por: Paioli, Anna, et al.
Publicado: (2017)

Erratum to: Osteosarcoma follow-up: chest X-ray or computed tomography?
por: Paioli, Anna, et al.
Publicado: (2017)

NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case report
por: Palmerini, Emanuela, et al.
Publicado: (2023)

The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas
por: Palmerini, Emanuela, et al.
Publicado: (2016)

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
por: Boye, Kjetil, et al.
Publicado: (2021)

Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results
por: Palmerini, Emanuela, et al.
Publicado: (2018)

Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group
por: Palmerini, Emanuela, et al.
Publicado: (2021)

Chondroblastoma’s Lung Metastases Treated with Denosumab in Pediatric Patient
por: Focaccia, Marco, et al.
Publicado: (2021)

Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis
por: Palmerini, Emanuela, et al.
Publicado: (2022)

Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study
por: Palmerini, Emanuela, et al.
Publicado: (2022)

IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience
por: Setola, Elisabetta, et al.
Publicado: (2023)

Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans
por: Palmerini, Emanuela, et al.
Publicado: (2012)

Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS)
por: Palmerini, Emanuela, et al.
Publicado: (2020)

How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience
por: Marchesi, Emanuela, et al.
Publicado: (2017)

Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study
por: Asaftei, Sebastian Dorin, et al.
Publicado: (2021)

Malignancy in Giant Cell Tumor of Bone: A Review of the Literature
por: Palmerini, Emanuela, et al.
Publicado: (2019)

Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy
por: Goracci, Martina, et al.
Publicado: (2020)

Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint Study
por: Abate, Massimo E., et al.
Publicado: (2021)

Phase 2 study for nonmetastatic extremity high‐grade osteosarcoma in pediatric and adolescent and young adult patients with a risk‐adapted strategy based on ABCB1/P‐glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS‐2)
por: Palmerini, Emanuela, et al.
Publicado: (2022)

Evaluation of Anlotinib Combined with Adriamycin and Ifosfamide as Conversion Therapy for Unresectable Soft Tissue Sarcomas
por: Long, Zuoyao, et al.
Publicado: (2023)

Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation
por: De Feo, Alessandra, et al.
Publicado: (2019)

Rare Primary Malignant Bone Sarcomas
por: Palmerini, Emanuela, et al.
Publicado: (2020)

EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing’s Sarcoma and Chondrosarcoma
por: Giordano, Giorgia, et al.
Publicado: (2021)

Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application
por: Agnoletto, Chiara, et al.
Publicado: (2023)

Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways
por: Pignochino, Ymera, et al.
Publicado: (2009)

Treatment options in unresectable soft tissue and bone sarcoma of the extremities and pelvis – a systematic literature review
por: Smolle, Maria Anna, et al.
Publicado: (2020)

Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1
por: Palmerini, Emanuela, et al.
Publicado: (2017)

Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
por: Palmerini, Emanuela, et al.
Publicado: (2021)

Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer
por: Chitapanarux, I, et al.
Publicado: (2010)

Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response?
por: Palmerini, Emanuela, et al.
Publicado: (2015)

The growing pains of ifosfamide
por: Sprangers, Ben, et al.
Publicado: (2020)

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.
por: Mesiano, Giulia, et al.
Publicado: (2018)

Intraosseous papillary intralymphatic angioendothelioma (PILA): one new case and review of the literature
por: Gambarotti, Marco, et al.
Publicado: (2018)

Doxorubicin and ifosfamide for recurrent renal synovial sarcoma: The first case report in Indonesia
por: Fitra, Ahmad Fathira, et al.
Publicado: (2022)

High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma
por: Sanfilippo, Roberta, et al.
Publicado: (2014)

High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma
por: Colia, Vittoria, et al.
Publicado: (2017)

Ifosfamide nephrotoxicity in adult patients
por: Ensergueix, Gaël, et al.
Publicado: (2019)

A Pharmacological Analysis of the Activity and Failure of the Medical Treatment of High-Grade Osteosarcoma
por: Comandone, Alessandro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rb1n2rdflm6t3ipli9kos4vgm3